Regulatory emergency order issued against Tokyo clinic for unapproved cell therapy
Japan's Ministry of Health, Labour and Welfare issued an emergency order under the Act on Safety of Regenerative Medicine, ordering Tokyo Clinic (ICVS) to halt provision of dendritic cell and activated lymphocyte therapy for advanced cancer after multiple severe disease cases were reported without required safety reports.
Why it matters. The order halts a specific unproven cell therapy being offered to cancer patients, highlighting regulatory oversight gaps and patient safety risks in the rapidly growing regenerative medicine sector.